October 6, 2011
Eli Lilly Japan announced on October 5 that it applied on the same day for approval of an additional dosage form of its antipsychotic treatment Zyprexa (olanzapine) as a fast-acting intramuscular injection. If approved, the drug will be Japan’s first...read more